294(top 1%)
PR articles
9.7K(top 1%)
PR citations
54(top 1%)
PR h-index
60(top 1%)
h-index
316
documents
12.1K
doc citations
3.0K
citing journals
100
times ranked

Publications

294 PR articles • 10,108 PR citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1Comprehensive Analysis of TSPAN32 Regulatory Networks and Their Role in Immune Cell Biology
Biomolecules, 2025, 15, 107
4.23Citations (PDF)
2Emerging Therapeutic Potential of Polyphenols from Geranium sanguineum L. in Viral Infections, Including SARS-CoV-2
Biomolecules, 2024, 14, 130
4.26Citations (PDF)
3Vitamin A Positively Correlates with Secretory Immunoglobulin A: A Cross-Sectional Study in Omicron COVID-19 Outpatients2.53Citations (PDF)
4Evaluation of Toll-like Receptor 4 (TLR4) Involvement in Human Atrial Fibrillation: A Computational Study
Genes, 2024, 15, 634
2.51Citations (PDF)
5Cytokine Signatures and Immune Dysregulation in COVID-19 Patients: Transcriptomic and Serum Analysis1.70Citations (PDF)
6Identification of Poliovirus Receptor-like 3 Protein as a Prognostic Factor in Triple-Negative Breast Cancer
Cells, 2024, 13, 1299
4.71Citations (PDF)
7Serum and urinary levels of MIF, CD74, DDT and CXCR4 among patients with type 1 diabetes mellitus, type 2 diabetes and healthy individuals: Implications for further research
Metabolism Open, 2024, 24, 100320
2.48Citations (PDF)
8Tetraspanin32 (TSPAN32) is downregulated in rheumatoid arthritis: Evidence from animal models and patients1.42Citations (PDF)
9Preventive and Therapeutic Effects of Punica granatum L. Polyphenols in Neurological Conditions4.417Citations (PDF)
10Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy2.5135Citations (PDF)
11Severe COVID-19: Drugs and Clinical Trials2.53Citations (PDF)
12Evaluation of the Involvement of Heme Oxygenase-1 Expression in Discoid Lupus Erythematosus Lesions
Antioxidants, 2023, 12, 1352
5.82Citations (PDF)
13Anti-COVID-19 Potential of Ellagic Acid and Polyphenols of Punica granatum L.
Molecules, 2023, 28, 3772
4.227Citations (PDF)
14Transcriptional upregulation of galectin-3 in multiple sclerosis
Immunologic Research, 2023, 71, 950-958
2.84Citations (PDF)
15Exploring the Role of CD74 and D-Dopachrome Tautomerase in COVID-19: Insights from Transcriptomic and Serum Analyses2.53Citations (PDF)
16The newly engineered monoclonal antibody ON104, targeting the oxidized Macrophage Migration Inhibitory Factor (oxMIF), ameliorates clinical and histopathological signs of collagen-induced arthritis4.35Citations (PDF)
17Evaluation of Cell-Specific Alterations in Alzheimer’s Disease and Relevance of In Vitro Models
Genes, 2023, 14, 2187
2.51Citations (PDF)
18Oral Delivery of Encapsulated All-Trans Retinoic Acid Ameliorates Disease in Rodent Models of Colitis
Inflammatory Bowel Diseases, 2022, 28, 455-465
2.96Citations (PDF)
19The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19
Drug Discovery Today, 2022, 27, 848-856
6.696Citations (PDF)
20Neuroprotective Effects of Myrtenal in an Experimental Model of Dementia Induced in Rats
Antioxidants, 2022, 11, 374
5.817Citations (PDF)
21Canonical (CD74/CD44) and Non-Canonical (CXCR2, 4 and 7) MIF Receptors Are Differentially Expressed in Rheumatoid Arthritis Patients Evaluated by DAS28-ESR2.516Citations (PDF)
22Characterization of Altered Molecular Pathways in the Entorhinal Cortex of Alzheimer’s Disease Patients and In Silico Prediction of Potential Repurposable Drugs
Genes, 2022, 13, 703
2.56Citations (PDF)
23Computational Analysis of Pathogenetic Pathways in Alzheimer’s Disease and Prediction of Potential Therapeutic Drugs
Brain Sciences, 2022, 12, 827
2.56Citations (PDF)
24Gene Co-Expression Network Modular Analysis Reveals Altered Immune Mechanisms in HIV-HAND
Brain Sciences, 2022, 12, 1378
2.55Citations (PDF)
25Polyamines serum levels in episodic and chronic migraine2.910Citations (PDF)
26Macrophage Migration Inhibitory Factor (MIF) and Its Homologue D-Dopachrome Tautomerase (DDT) Inversely Correlate with Inflammation in Discoid Lupus Erythematosus
Molecules, 2021, 26, 184
4.214Citations (PDF)
27Cognitive Decline in Rheumatoid Arthritis: Insight into the Molecular Pathogenetic Mechanisms4.439Citations (PDF)
28Inverse correlation between plasma 2‐arachidonoylglycerol levels and subjective severity of depression1.721Citations (PDF)
29Identification of Common Pathogenetic Processes between Schizophrenia and Diabetes Mellitus by Systems Biology Analysis
Genes, 2021, 12, 237
2.521Citations (PDF)
30Potential Mucosal Irritation Discrimination of Surface Disinfectants Employed against SARS-CoV-2 by Limacus flavus Slug Mucosal Irritation Assay
Biomedicines, 2021, 9, 424
3.411Citations (PDF)
31A Network Medicine Approach for Drug Repurposing in Duchenne Muscular Dystrophy
Genes, 2021, 12, 543
2.511Citations (PDF)
32Selective reduction in the expression of type‐1 metabotropic glutamate receptors in the hippocampus of adult rats born by caesarean section1.53Citations (PDF)
33Altered Expression of TSPAN32 during B Cell Activation and Systemic Lupus Erythematosus
Genes, 2021, 12, 931
2.59Citations (PDF)
34Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis6.630Citations (PDF)
35Transcriptomic Data Analysis Reveals a Down-Expression of Galectin-8 in Schizophrenia Hippocampus
Brain Sciences, 2021, 11, 973
2.54Citations (PDF)
36Therapeutic Potential of Alpha-Lipoic Acid in Viral Infections, including COVID-19
Antioxidants, 2021, 10, 1294
5.827Citations (PDF)
37A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies2.237Citations (PDF)
38Food toxicology: quantitative analysis of the research field literature3.215Citations (PDF)
39Pathogenic contribution of the Macrophage migration inhibitory factor family to major depressive disorder and emerging tailored therapeutic approaches4.547Citations (PDF)
40Novel 3,3-disubstituted oxindole derivatives. Synthesis and evaluation of the anti-proliferative activity2.024Citations (PDF)
41In Silico and In Vivo Analysis of IL37 in Multiple Sclerosis Reveals Its Probable Homeostatic Role on the Clinical Activity, Disability, and Treatment with Fingolimod
Molecules, 2020, 25, 20
4.227Citations (PDF)
42Effects of Combined Admistration of Imatinib and Sorafenib in a Murine Model of Liver Fibrosis
Molecules, 2020, 25, 4310
4.28Citations (PDF)
43Comprehensive Analysis of RNA-Seq Gene Expression Profiling of Brain Transcriptomes Reveals Novel Genes, Regulators, and Pathways in Autism Spectrum Disorder
Brain Sciences, 2020, 10, 747
2.560Citations (PDF)
44Upregulation of Tolerogenic Pathways by the Hydrogen Sulfide Donor GYY4137 and Impaired Expression of H2S-Producing Enzymes in Multiple Sclerosis
Antioxidants, 2020, 9, 608
5.815Citations (PDF)
45Emerging Neurological and Psychobiological Aspects of COVID-19 Infection
Brain Sciences, 2020, 10, 852
2.535Citations (PDF)
46Immune-Modulating Drug MP1032 with SARS-CoV-2 Antiviral Activity In Vitro: A potential Multi-Target Approach for Prevention and Early Intervention Treatment of COVID-194.47Citations (PDF)
47Preventive Effect of a Polyphenol-Rich Extract from Geranium sanguineum L. on Hepatic Drug Metabolism in Influenza Infected Mice2.16Citations (PDF)
48Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies
Autoimmunity Reviews, 2020, 19, 102571
7.199Citations (PDF)
49Exploratory Analysis of iPSCS-Derived Neuronal Cells as Predictors of Diagnosis and Treatment of Alzheimer Disease
Brain Sciences, 2020, 10, 166
2.515Citations (PDF)
50The cytokine network in the pathogenesis of major depressive disorder. Close to translation?
Autoimmunity Reviews, 2020, 19, 102504
7.179Citations (PDF)
51Emerging Role of the Macrophage Migration Inhibitory Factor Family of Cytokines in Neuroblastoma. Pathogenic Effectors and Novel Therapeutic Targets?
Molecules, 2020, 25, 1194
4.239Citations (PDF)
52The Effect of Omega-3 Fatty Acids on Capsular Tissue around the Breast Implants1.821Citations (PDF)
53Neuroprotective Mechanisms of Three Natural Antioxidants on a Rat Model of Parkinson’s Disease: A Comparative Study
Antioxidants, 2020, 9, 49
5.840Citations (PDF)
54Impaired Expression of Tetraspanin 32 (TSPAN32) in Memory T Cells of Patients with Multiple Sclerosis
Brain Sciences, 2020, 10, 52
2.520Citations (PDF)
55The Role of Macrophage Migration Inhibitory Factor in Alzheimer′s Disease: Conventionally Pathogenetic or Unconventionally Protective?
Molecules, 2020, 25, 291
4.243Citations (PDF)
56The Dichotomic Role of Macrophage Migration Inhibitory Factor in Neurodegeneration4.425Citations (PDF)
57Transcriptomic Analysis Reveals Abnormal Expression of Prion Disease Gene Pathway in Brains from Patients with Autism Spectrum Disorders
Brain Sciences, 2020, 10, 200
2.52Citations (PDF)
58Meta-Analysis of Transcriptomic Data of Dorsolateral Prefrontal Cortex and of Peripheral Blood Mononuclear Cells Identifies Altered Pathways in Schizophrenia
Genes, 2020, 11, 390
2.518Citations (PDF)
59Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review)4.478Citations (PDF)
60Transcriptomic analysis of COVID‑19 lungs and bronchoalveolar lavage fluid samples reveals predominant B cell activation responses to infection4.434Citations (PDF)
61Profiling of inhibitory immune checkpoints in glioblastoma: Potential pathogenetic players
Oncology Letters, 2020, 20,
1.913Citations (PDF)
62Transcriptomic analysis reveals moderate modulation of macrophage migration inhibitory factor superfamily genes in alcohol use disorders2.05Citations (PDF)
63Retrospective follow-up analysis of the transcriptomic patterns of cytokines, cytokine receptors and chemokines at preconception and during pregnancy, in women with post-partum depression2.024Citations (PDF)
64Characterization of the Pathophysiological Role of CD47 in Uveal Melanoma
Molecules, 2019, 24, 2450
4.232Citations (PDF)
65Upregulation of IL-1 Receptor Antagonist in a Mouse Model of Migraine
Brain Sciences, 2019, 9, 172
2.530Citations (PDF)
66Upregulated Expression of Macrophage Migration Inhibitory Factor, Its Analogue D-Dopachrome Tautomerase, and the CD44 Receptor in Peripheral CD4 T Cells from Clinically Isolated Syndrome Patients with Rapid Conversion to Clinical Defined Multiple Sclerosis
Medicina (Lithuania), 2019, 55, 667
2.128Citations (PDF)
67Overexpression of Macrophage Migration Inhibitory Factor and Its Homologue D-Dopachrome Tautomerase as Negative Prognostic Factor in Neuroblastoma
Brain Sciences, 2019, 9, 284
2.535Citations (PDF)
68Prediction of PD-L1 Expression in Neuroblastoma via Computational Modeling
Brain Sciences, 2019, 9, 221
2.525Citations (PDF)
69Modulation of Tetraspanin 32 (TSPAN32) Expression in T Cell-Mediated Immune Responses and in Multiple Sclerosis4.431Citations (PDF)
70Orally delivered all-trans-retinoic acid- and transforming growth factor-β-loaded microparticles ameliorate type 1 diabetes in mice4.322Citations (PDF)
71Identification of CD4+ T cell biomarkers for predicting the response of patients with relapsing‑remitting multiple sclerosis to natalizumab treatment2.829Citations (PDF)
72Prevention of clinical and histological signs of MOG-induced experimental allergic encephalomyelitis by prolonged treatment with recombinant human EGF
Journal of Neuroimmunology, 2019, 332, 224-232
2.332Citations (PDF)
73Senescence as a main mechanism of Ritonavir and Ritonavir‐NO action against melanoma
Molecular Carcinogenesis, 2019, 58, 1362-1375
3.118Citations (PDF)
74KCNMA1 Expression Is Downregulated in Colorectal Cancer via Epigenetic Mechanisms
Cancers, 2019, 11, 245
3.828Citations (PDF)
75Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo
Investigational New Drugs, 2019, 37, 1014-1028
2.547Citations (PDF)
76Immunobiology of Uveal Melanoma: State of the Art and Therapeutic Targets2.647Citations (PDF)
77Effects of Treatment with the Hypomethylating Agent 5-aza-2′-deoxycytidine in Murine Type II Collagen-Induced Arthritis
Pharmaceuticals, 2019, 12, 174
4.219Citations (PDF)
78Transcriptomic Analysis Reveals Involvement of the Macrophage Migration Inhibitory Factor Gene Network in Duchenne Muscular Dystrophy
Genes, 2019, 10, 939
2.519Citations (PDF)
79Role of MIF and D-DT in immune-inflammatory, autoimmune, and chronic respiratory diseases: from pathogenic factors to therapeutic targets
Drug Discovery Today, 2019, 24, 428-439
6.694Citations (PDF)
80Differential modulation and prognostic values of immune-escape genes in uveal melanoma
PLoS ONE, 2019, 14, e0210276
2.353Citations (PDF)
81Stress as risk factor for Alzheimer’s disease
Pharmacological Research, 2018, 132, 130-134
9.192Citations (PDF)
82Naturally occurring compounds in differentiation based therapy of cancer
Biotechnology Advances, 2018, 36, 1622-1632
11.844Citations (PDF)
83Involvement of the Nrf2/HO‐1/CO axis and therapeutic intervention with the CO‐releasing molecule CORM‐A1, in a murine model of autoimmune hepatitis
Journal of Cellular Physiology, 2018, 233, 4156-4165
4.154Citations (PDF)
84Letter to the Editor Regarding: A Comprehensive Review on Copemyl®
Neurology and Therapy, 2018, 7, 385-390
3.81Citations (PDF)
85The H2S Donor GYY4137 Stimulates Reactive Oxygen Species Generation in BV2 Cells While Suppressing the Secretion of TNF and Nitric Oxide
Molecules, 2018, 23, 2966
4.224Citations (PDF)
86Multimodal antidepressant vortioxetine causes analgesia in a mouse model of chronic neuropathic pain
Molecular Pain, 2018, 14,
2.432Citations (PDF)
87Anticancer and Differentiation Properties of the Nitric Oxide Derivative of Lopinavir in Human Glioblastoma Cells
Molecules, 2018, 23, 2463
4.238Citations (PDF)
88Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences
Journal of Neuroimmunology, 2018, 322, 46-56
2.375Citations (PDF)
89Gasotransmitters and the immune system: Mode of action and novel therapeutic targets4.360Citations (PDF)
90Ageing: from inflammation to cancer5.0217Citations (PDF)
91The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic Targets4.4159Citations (PDF)
92Phytol: A review of biomedical activities3.5364Citations (PDF)
93Overexpression of macrophage migration inhibitory factor and functionally‑related genes, D‑DT, CD74, CD44, CXCR2 and CXCR4, in glioblastoma1.954Citations (PDF)
94Decitabine induces regulatory T cells, inhibits the production of IFN-gamma and IL-17 and exerts preventive and therapeutic efficacy in rodent experimental autoimmune neuritis
Journal of Neuroimmunology, 2018, 321, 41-48
2.320Citations (PDF)
95Primary antiphospholipid syndrome and antiphospholipid syndrome associated to systemic lupus: Are they different entities?
Autoimmunity Reviews, 2018, 17, 739-745
7.130Citations (PDF)
96Potential Use of Modulators of Oxidative Stress as Add-on Therapy in Patients with Anxiety Disorders
Current Drug Targets, 2018, 19, 636-650
2.17Citations (PDF)
97Identification of novel chemotherapeutic strategies for metastatic uveal melanoma3.450Citations (PDF)
98Evaluation of hyaluronic acid-P40 conjugated cream in a mouse model of dermatitis induced by oxazolone2.019Citations (PDF)
99HIV‐protease inhibitors for the treatment of cancer: Repositioning HIV protease inhibitors while developing more potent NO‐hybridized derivatives?
International Journal of Cancer, 2017, 140, 1713-1726
4.375Citations (PDF)
100Diagnostic utility of cyclin D1 in the diagnosis of small round blue cell tumors in children and adolescents
Human Pathology, 2017, 60, 58-65
2.324Citations (PDF)
101Standardized bovine colostrum derivative impedes development of type 1 diabetes in rodents
Immunobiology, 2017, 222, 272-279
1.19Citations (PDF)
102Anti-angiogenic Therapy in Cancer: Downsides and New Pivots for Precision Medicine3.868Citations (PDF)
103Dickkopf-3 Upregulates VEGF in Cultured Human Endothelial Cells by Activating Activin Receptor-Like Kinase 1 (ALK1) Pathway3.828Citations (PDF)
104Shedding of Microvesicles from Microglia Contributes to the Effects Induced by Metabotropic Glutamate Receptor 5 Activation on Neuronal Death3.828Citations (PDF)
105Effects of Synthetic Anti-Inflammatory Sterol in CB3V-Induced Myocarditis: A Morphological Study on Heart Muscle Tissue2.111Citations (PDF)
106Computational Modeling of PI3K/AKT and MAPK Signaling Pathways in Melanoma Cancer
PLoS ONE, 2016, 11, e0152104
2.359Citations (PDF)
107CD4+ T-cell gene expression of healthy donors, HIV-1 and elite controllers: Immunological chaos
Cytokine, 2016, 83, 127-135
3.515Citations (PDF)
108Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity—Diverse effects on cell growth, metabolism and cancer3.6153Citations (PDF)
109Induction of OAS gene family in HIV monocyte infected patients with high and low viral load
Antiviral Research, 2016, 131, 66-73
3.849Citations (PDF)
110The therapeutic potential of mTOR inhibitors in breast cancer2.6113Citations (PDF)
111Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer’s disease
Pharmacological Research, 2016, 105, 186-197
9.151Citations (PDF)
112Expression of DNA methylation genes in secondary progressive multiple sclerosis
Journal of Neuroimmunology, 2016, 290, 66-69
2.320Citations (PDF)
113Emerging therapeutic targets for the treatment of hepatic fibrosis
Drug Discovery Today, 2016, 21, 369-375
6.672Citations (PDF)
114Effects of NO-Hybridization on the Immunomodulatory Properties of the HIV Protease Inhibitors Lopinavir and Ritonavir2.820Citations (PDF)
115Oral Delivery of Particulate Transforming Growth Factor Beta 1 and All-Trans Retinoic Acid Reduces Gut Inflammation in Murine Models of Inflammatory Bowel Disease1.326Citations (PDF)
116Cyclin D1 in pediatric neuroblastic tumors: A microarray analysis
Acta Histochemica, 2015, 117, 820-823
2.34Citations (PDF)
117Identification of novel targets for the diagnosis and treatment of liver fibrosis4.447Citations (PDF)
118Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity
Cancer Research, 2015, 75, 3747-3759
3.8114Citations (PDF)
119Carbon monoxide-releasing molecule-A1 (CORM-A1) improves clinical signs of experimental autoimmune uveoretinitis (EAU) in rats
Clinical Immunology, 2015, 157, 198-204
2.739Citations (PDF)
120Crude extract of hydatid laminated layer from Echinococcus granulosus cyst attenuates mucosal intestinal damage and inflammatory responses in Dextran Sulfate Sodium induced colitis in mice4.049Citations (PDF)
121Cyclin D1 and Ewing's sarcoma/PNET: A microarray analysis
Acta Histochemica, 2015, 117, 824-828
2.310Citations (PDF)
122An update on the cerebellar subtype of multiple system atrophy1.825Citations (PDF)
123Saquinavir‐<scp>NO</scp> Inhibits <scp>IL</scp>‐6 Production in Macrophages2.83Citations (PDF)
124Acceleration of SLE-like syndrome development in NZBxNZW F1 mice by beta-glucan
Lupus, 2014, 23, 407-411
1.716Citations (PDF)
125Hypomethylating Agent 5‐Aza‐2′‐deoxycytidine (DAC) Ameliorates Multiple Sclerosis in Mouse Models
Journal of Cellular Physiology, 2014, 229, 1918-1925
4.152Citations (PDF)
126Effects of vitamin B12 on the corneal nerve regeneration in rats
Experimental Eye Research, 2014, 120, 109-117
2.537Citations (PDF)
127Pharmacological application of carbon monoxide ameliorates islet-directed autoimmunity in mice via anti-inflammatory and anti-apoptotic effects
Diabetologia, 2014, 57, 980-990
7.673Citations (PDF)
128Diverse roles of GSK-3: Tumor promoter–tumor suppressor, target in cancer therapy2.084Citations (PDF)
129Targeting breast cancer initiating cells: Advances in breast cancer research and therapy2.033Citations (PDF)
130Low-Dose Acetazolamide in the Treatment of Premenstrual Dysphoric Disorder: A Case Series1.65Citations (PDF)
131Heme oxygenase-1 expression in peripheral blood mononuclear cells correlates with disease activity in multiple sclerosis
Journal of Neuroimmunology, 2013, 261, 82-86
2.348Citations (PDF)
132Exposure to predator odor and resulting anxiety enhances the expression of the α2δ subunit of voltage‐sensitive calcium channels in the amygdala
Journal of Neurochemistry, 2013, 125, 649-656
3.819Citations (PDF)
133Association of chitotriosidase genotype with the development of non‐alcoholic fatty liver disease
Hepatology Research, 2013, 43, 267-275
2.926Citations (PDF)
134Apotransferrin inhibits interleukin-2 expression and protects mice from experimental autoimmune encephalomyelitis
Journal of Neuroimmunology, 2013, 262, 72-78
2.37Citations (PDF)
135Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferon-gamma and ameliorates experimental autoimmune encephalomyelitis
Journal of Neuroimmunology, 2013, 259, 55-65
2.39Citations (PDF)
136No-Modified Saquinavir is Equally Efficient Against Doxorubicin Sensitive and Resistant Non-Small Cell Lung Carcinoma Cells / MODIFIKOVANA KOVANA FORMA SAKVINAVIRA EFIKASNO SU PRIMI RA RAST ĆELIJA NESITNOĆELIJSKOG KARCINOMA PLUĆA RAZLIČITE OSETUIVOSTI NA DOKSORUBICIN1.52Citations (PDF)
137Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention
Leukemia, 2013, 28, 15-33
7.7248Citations (PDF)
138Pregabalin in the Treatment of Chronic Pain
Clinical Drug Investigation, 2012, 29, 203-213
2.151Citations (PDF)
139BRAF inhibition improves tumor recognition by the immune system
OncoImmunology, 2012, 1, 1476-1483
5.482Citations (PDF)
140Modulation of heat shock proteins during macrophage differentiation
Inflammation Research, 2012, 61, 1131-1139
4.834Citations (PDF)
141Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease
Neurobiology of Aging, 2012, 33, 1121.e1-1121.e12
3.487Citations (PDF)
142Unique antineoplastic profile of Saquinavir-NO, a novel NO-derivative of the protease inhibitor Saquinavir, on the in vitro and in vivo tumor formation of A375 human melanoma cells
Oncology Reports, 2012, 28, 682-688
2.818Citations (PDF)
143Resistance to TRAIL and how to surmount it
Immunologic Research, 2012, 52, 157-168
2.852Citations (PDF)
144Therapeutic potential of carbon monoxide in multiple sclerosis3.459Citations (PDF)
145Macrophage migration inhibitory factor deficiency protects pancreatic islets from cytokine-induced apoptosis in vitro3.433Citations (PDF)
146The immunobiology of apotransferrin in type 1 diabetes3.410Citations (PDF)
147Novel Benzo[b]thiophene Derivatives as New Potential Antidepressants with Rapid Onset of Action
Journal of Medicinal Chemistry, 2011, 54, 3086-3090
5.6102Citations (PDF)
148The conditioned eyeblink reflex: a potential tool for the detection of cerebellar dysfunction in multiple sclerosis
Multiple Sclerosis Journal, 2011, 17, 1155-1161
3.94Citations (PDF)
149Pharmacology and immune modulating properties of 5-androstene-3β,7β,17β-triol, a DHEA metabolite in the human metabolome2.313Citations (PDF)
150Novel components of the human metabolome: The identification, characterization and anti-inflammatory activity of two 5-androstene tetrols
Steroids, 2011, 76, 145-155
2.020Citations (PDF)
151The second-to-fourth digit ratio correlates with the rate of academic performance in medical school students2.825Citations (PDF)
152Phase II study of the antiretroviral activity and safety of the glucocorticoid receptor antagonist mifepristone in HIV-1-infected patients4.44Citations (PDF)
153Prevention of clinical and histological signs of proteolipid protein (PLP)-induced experimental allergic encephalomyelitis (EAE) in mice by the water-soluble carbon monoxide-releasing molecule (CORM)-A13.467Citations (PDF)
154Vitamin D3: a helpful immuno-modulator
Immunology, 2011, 134, 123-139
4.7390Citations (PDF)
155Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway
Leukemia, 2011, 25, 1064-1079
7.7200Citations (PDF)
156Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy
Leukemia, 2011, 25, 1080-1094
7.7251Citations (PDF)
157Hyperalgesic Activity of Kisspeptin in Mice
Molecular Pain, 2011, 7,
2.420Citations (PDF)
158mTOR as a multifunctional therapeutic target in HIV infection
Drug Discovery Today, 2011, 16, 715-721
6.694Citations (PDF)
159HE3286, an orally bioavailable synthetic analogue of an active DHEA metabolite suppresses spontaneous autoimmune diabetes in the non-obese diabetic (NOD) mouse4.39Citations (PDF)
160The new and less toxic protease inhibitor saquinavir–NO maintains anti-HIV-1 properties in vitro indistinguishable from those of the parental compound saquinavir
Antiviral Research, 2011, 91, 292-295
3.89Citations (PDF)
161Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways
Journal of Cellular Physiology, 2011, 226, 2762-2781
4.1159Citations (PDF)
162Oral treatment with HE3286 ameliorates disease in rodent models of rheumatoid arthritis4.411Citations (PDF)
163Extrahepatic disorders of HCV infection: A distinct entity of B-cell neoplasia?3.836Citations (PDF)
164Prevalence of hepatitis C virus infection among health-care workers: A 10-year survey2.811Citations (PDF)
165HE3286, an oral synthetic steroid, treats lung inflammation in mice without immune suppression4.011Citations (PDF)
166Specific and Strain-Independent Effects of Dexamethasone in the Prevention and Treatment of Experimental Autoimmune Encephalomyelitis in Rodents1.428Citations (PDF)
167Anticancer Effects of the Nitric Oxide-Modified Saquinavir Derivative Saquinavir-NO against Multidrug-Resistant Cancer Cells
Neoplasia, 2010, 12, 1023-IN17
7.051Citations (PDF)
168The advent of monoclonal antibodies in the treatment of chronic autoimmune diseases
Neurological Sciences, 2010, 31, 283-288
1.731Citations (PDF)
169Computational Evaluation of Yin Yang 1 Transcript Levels in the Spectrum of B-cell Neoplasia0.01Citations (PDF)
170Rationale for Targeting of YY1 in Drug-resistant Leukemias0.01Citations (PDF)
171HE3286: A Novel Synthetic Steroid as an Oral Treatment for Autoimmune Disease4.019Citations (PDF)
172PIK3CA mutations in human solid tumors: Role in sensitivity to various therapeutic approaches
Cell Cycle, 2009, 8, 1352-1358
3.2204Citations (PDF)
173The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: The elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy
Journal of Neuroimmunology, 2009, 207, 101-106
2.379Citations (PDF)
174MIF in autoimmunity and novel therapeutic approaches
Autoimmunity Reviews, 2009, 8, 244-249
7.189Citations (PDF)
175Molecular mechanisms involved in NAFLD progression3.7262Citations (PDF)
17616α-Bromoepiandrosterone (HE2000) limits non-productive inflammation and stimulates immunity in lungs3.412Citations (PDF)
177Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin3.454Citations (PDF)
178Simultaneous analysis of diazepam and its metabolites in rat plasma and brain tissue by HPLC-UV and SPE
Talanta, 2009, 80, 279-285
5.953Citations (PDF)
179Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells
Journal of Autoimmunity, 2009, 33, 135-140
6.673Citations (PDF)
180The interplay of two single nucleotide polymorphisms in the CACNA1A gene may contribute to migraine susceptibility
Neuroscience Letters, 2009, 453, 12-15
1.914Citations (PDF)
181Lyrica Cures the Tenor1.13Citations (PDF)
182Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus
Journal of Cellular Physiology, 2008, 215, 665-675
4.182Citations (PDF)
183Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance
Leukemia, 2008, 22, 2080-2090
7.772Citations (PDF)
184Effects of the immunomodulator, VGX‐1027, in endotoxin‐induced uveitis in Lewis rats6.310Citations (PDF)
185Enhanced expression of Harvey ras induced by serum deprivation in cultured astrocytes
Journal of Neurochemistry, 2008, 106, 551-559
3.86Citations (PDF)
186Preventive and curative effects of cyclophosphamide in an animal model of Guillain Barrè syndrome
Journal of Neuroimmunology, 2008, 196, 107-115
2.311Citations (PDF)
187Association of t(14;18) translocation with HCV infection in gastrointestinal MALT lymphomas
Journal of Hepatology, 2008, 49, 170-174
4.232Citations (PDF)
188Neuroprotective effect of prenyloxycoumarins from edible vegetables
Neuroscience Letters, 2008, 443, 57-60
1.955Citations (PDF)
189Group I metabotropic glutamate receptors control proliferation, survival and differentiation of cultured neural progenitor cells isolated from the subventricular zone of adult mice
Neuropharmacology, 2008, 55, 560-567
4.349Citations (PDF)
190Akt as a therapeutic target in cancer3.7137Citations (PDF)
191Targeting the leukemic stem cell: the Holy Grail of leukemia therapy
Leukemia, 2008, 23, 25-42
7.7180Citations (PDF)
192Control of the of the final stage of immune-mediated diabetes by ISO-1, an antagonist of macrophage migration inhibitory factor0.79Citations (PDF)
19317a‐ethynyl‐5‐androsten‐3ß, 7ß, 17ß‐triol (HE3286): a novel synthetic steroid with broad based anti‐inflammatory activity
FASEB Journal, 2008, 22,
0.60Citations (PDF)
194Maternal Exposure to Low Levels of Corticosterone during Lactation Protects the Adult Offspring against Ischemic Brain Damage
Journal of Neuroscience, 2007, 27, 7041-7046
3.737Citations (PDF)
195Vaccination with IL-6 analogues induces autoantibodies to IL-6 and influences experimentally induced inflammation4.214Citations (PDF)
196Imbalance in Seminal Fluid MIF Indicates Male Infertility
Molecular Medicine, 2007, 13, 199-202
5.621Citations (PDF)
197Beneficial effects of r-h-CLU on disease severity in different animal models of peripheral neuropathies2.323Citations (PDF)
198Effects of Tumour Necrosis Factor-α on Human Sperm Motility and Apoptosis3.1149Citations (PDF)
199Analysis of interleukin (IL)-1β IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders2.87Citations (PDF)
200Anti-inflammatory and Immune Regulatory Properties of 5-Androsten-3β, 17β-Diol (HE2100), and Synthetic Analogue HE3204: Implications for Treatment of Autoimmune Diseases4.015Citations (PDF)
201Somatostatin and the somatostatin receptor 2 are reciprocally controlled by calcineurin during cerebellar granule cell maturation
Journal of Neurochemistry, 2005, 94, 1374-1383
3.84Citations (PDF)
202Clinical characteristics, beta-cell function, HLA class II and mutations in MODY genes in non-paediatric subjects with Type 1 diabetes without pancreatic autoantibodies
Diabetic Medicine, 2005, 22, 137-143
2.911Citations (PDF)
203Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain–Barré syndrome and experimental allergic neuritis
Journal of Neuroimmunology, 2005, 168, 168-174
2.365Citations (PDF)
204Interleukin (IL)-1? toxicity to islet ? cells: Efaroxan exerts a complete protection4.119Citations (PDF)
205Extracellular lysosome-associated membrane protein-1 (LAMP-1) mediates autoimmune disease progression in the NOD model of type 1 diabetes
European Journal of Immunology, 2005, 35, 1501-1509
3.23Citations (PDF)
206Lack of effect of intermittently administered sodium fusidate in patients with newly diagnosed type 1 diabetes mellitus: the FUSIDM trial
Diabetologia, 2005, 48, 1464-1468
7.611Citations (PDF)
207Critical Role of Macrophage Migration Inhibitory Factor Activity in Experimental Autoimmune Diabetes
Endocrinology, 2005, 146, 2942-2951
2.5117Citations (PDF)
208Elevated serum levels of osteopontin in HCV-associated lymphoproliferative disorders
Cancer Biology and Therapy, 2005, 4, 1192-1194
4.127Citations (PDF)
209ISO-1 Binding to the Tautomerase Active Site of MIF Inhibits Its Pro-inflammatory Activity and Increases Survival in Severe Sepsis
Journal of Biological Chemistry, 2005, 280, 36541-36544
2.2278Citations (PDF)
210IL-18 binding protein fusion construct delays the development of diabetes in adoptive transfer and cyclophosphamide-induced diabetes in NOD mouse
Clinical Immunology, 2005, 115, 74-79
2.740Citations (PDF)
211Biological Profile of Cortexolone 17a-Propionate (CB-03-01), a New Topical and Peripherally Selective Androgen Antagonist
Arzneimittelforschung, 2004, 54, 881-886
0.815Citations (PDF)
212Exacerbation of protracted-relapsing experimental allergic encephalomyelitis in DA rats by gluten-free diet
Apmis, 2004, 112, 651-5
2.517Citations (PDF)
213Protective effects of estradiol on TRAIL-induced apoptosis in a human oligodendrocytic cell line: evidence for multiple sites of interactions13.331Citations (PDF)
214Interleukin-11 Inhibits N-κB and AP-1 Activation in Islets and Prevents Diabetes Induced with Streptozotocin in Mice2.435Citations (PDF)
215Synergistic effect of deoxyspergualin (DSP) and cyclosporin A (CsA) in the prevention of spontaneous autoimmune diabetes in BB rats3.42Citations (PDF)
216Genetic differences in immune reactivity to mercuric chloride (HgCl2 ): immunosuppression of H-2d mice is mediated by interferon-gamma (IFN-γ)3.410Citations (PDF)
217Protection from concanavalin A (Con A)-induced T cell-dependent hepatic lesions and modulation of cytokine release in mice by sodium fusidate3.420Citations (PDF)
218Essential pathogenic role of endogenous IL-18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL-18-binding protein: Fc construct
European Journal of Immunology, 2003, 33, 2278-2286
3.239Citations (PDF)
219New Pyrimido[5,4-b]indoles as Ligands for α1-Adrenoceptor Subtypes
Journal of Medicinal Chemistry, 2003, 46, 2877-2894
5.636Citations (PDF)
220Insulin lispro is as effective as regular insulin in optimising metabolic control and preserving β-cell function at onset of type 1 diabetes mellitus5.924Citations (PDF)
221Curative effects of sodium fusidate on the development of dinitrobenzenesulfonic acid-induced colitis in rats
Clinical Immunology, 2003, 109, 266-271
2.76Citations (PDF)
222Proinflammatory effects of exogenously administered IL-10 in experimental autoimmune orchitis
Cytokine, 2003, 22, 50-53
3.515Citations (PDF)
223Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice1
Transplantation, 2002, 74, 611-619
2.126Citations (PDF)
224Prevention of Murine Experimental Autoimmune Orchitis by Recombinant Human Interleukin-6
Clinical Immunology, 2002, 102, 135-137
2.717Citations (PDF)
225An Imidazoline Compound Completely Counteracts Interleukin-1β toxic Effects to Rat Pancreatic Islet β Cells
Molecular Medicine, 2002, 8, 536-545
5.614Citations (PDF)
226Short-term prophylaxis with deoxyspergualin prevents testicular autoimmunity in mice4.35Citations (PDF)
227Autoimmune thyroid disease induced by thyroglobulin and lipopolysaccharide is inhibited by soluble TNF receptor type I
European Journal of Immunology, 2002, 32, 1021-1028
3.224Citations (PDF)
228Serum concentrations of the interferon-γ-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease
Diabetologia, 2002, 45, 1107-1110
7.6169Citations (PDF)
229Essential pathogenic role for endogenous interferon-gamma (IFN-γ) during disease onset phase of murine experimental autoimmune orchitis. I. In vivo studies3.446Citations (PDF)
230Blood levels of transforming growth factor-beta 1 (TGF-β1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-β1b)3.477Citations (PDF)
231Effect of octreotide on insulin requirement, hepatic glucose production, growth hormone, glucagon and c-peptide levels in type 2 diabetic patients with chronic renal failure or normal renal function5.913Citations (PDF)
232Serum levels of the interferon-γ-inducing cytokine interleukin-18 are increased in individuals at high risk of developing Type I diabetes
Diabetologia, 2001, 44, 309-311
7.687Citations (PDF)
233MFP14, a multifunctional emerging protein with immunomodulatory properties, prevents spontaneous and recurrent autoimmune diabetes in NOD mice
Diabetologia, 2001, 44, 839-847
7.610Citations (PDF)
234Curative effects of recombinant human Interleukin-6 in DA rats with protracted relapsing experimental allergic encephalomyelitis
Journal of Neuroimmunology, 2001, 116, 168-177
2.329Citations (PDF)
235Prevention and Treatment of Lethal Murine Endotoxemia by the Novel Immunomodulatory Agent MFP-144.12Citations (PDF)
236Sodium fusidate (fusidin) ameliorates the course of monophasic experimental allergic encephalomyelitis in the Lewis rat
Multiple Sclerosis Journal, 2001, 7, 101-104
3.98Citations (PDF)
237Dichotomic effects of IFN-γ on the development of systemic lupus erythematosus-like syndrome in MRL-lpr / lpr mice3.252Citations (PDF)
238Exogenous type-1 cytokines modulate mercury-induced hyper-IgE in the rat3.410Citations (PDF)
239Time-course and dose–response study on the effects of chronic l-DOPA administration on striatal dopamine levels and dopamine transporter following MPTP toxicity
Brain Research, 2000, 887, 110-117
2.540Citations (PDF)
240Neuroprotective activity of chemokines against N-methyl-d-aspartate or β-amyloid-induced toxicity in culture4.3110Citations (PDF)
241Murine Concanavalin A–Induced Hepatitis Is Prevented by Interleukin 12 (IL-12) Antibody and Exacerbated by Exogenous IL-12 Through an Interferon-γ–Dependent Mechanism
Hepatology, 2000, 32, 728-733
10.180Citations (PDF)
242Prevention of Spontaneous Autoimmune Diabetes in NOD Mice by Transferringin VitroAntigen-Pulsed Syngeneic Dendritic Cells1
Endocrinology, 2000, 141, 1500-1505
2.554Citations (PDF)
243The Antiinflammatory Cytokine Interleukin-13 is not Detectable in the Circulation of Multiple Sclerosis Patients and is not Inducible by Interferon-β 1b Treatment, that Neither Modifies its ex vivo Secretion from Peripheral Blood Mononuclear Cells
Autoimmunity, 2000, 32, 265-270
3.14Citations (PDF)
244ESSENTIAL PATHOGENETIC ROLE FOR INTERFERON (IFN-)γ IN CONCANAVALIN A-INDUCED T CELL-DEPENDENT HEPATITIS: EXACERBATION BY EXOGENOUS IFN-γ AND PREVENTION BY IFN-γ RECEPTOR-IMMUNOGLOBULIN FUSION PROTEIN
Cytokine, 2000, 12, 315-323
3.552Citations (PDF)
245SHORT-TERM TREATMENT OF RELAPSING REMITTING MULTIPLE SCLEROSIS PATIENTS WITH INTERFERON (IFN)-β1B TRANSIENTLY INCREASES THE BLOOD LEVELS OF INTERLEUKIN (IL)-6, IL-10 AND IFN-γ WITHOUT SIGNIFICANTLY MODIFYING THOSE OF IL-1β, IL-2, IL-4 AND TUMOUR NECROSIS FACTOR-α
Cytokine, 2000, 12, 682-687
3.533Citations (PDF)
246Endothelial Activation by aPL: A Potential Pathogenetic Mechanism for the Clinical Manifestations of the Syndrome
Journal of Autoimmunity, 2000, 15, 237-240
6.6140Citations (PDF)
247Sodium Fusidate Ameliorates the Course of Diabetes Induced in Mice by Multiple Low Doses of Streptozotocin
Journal of Autoimmunity, 2000, 15, 395-405
6.69Citations (PDF)
248Prevention of Spontaneous Autoimmune Diabetes in NOD Mice by Transferring in Vitro Antigen-Pulsed Syngeneic Dendritic Cells
Endocrinology, 2000, 141, 1500-1505
2.526Citations (PDF)
249Failure of Exogenously Administered Interferon-γ or Blockage of Endogenous Interleukin-4 with Specific Inhibitors to Augment the Incidence of Autoimmune Diabetes in Male NOD Mice
Autoimmunity, 1999, 30, 71-80
3.13Citations (PDF)
250Concanavalin A-induced Hepatitis in Mice is Prevented by Interleukin (IL)-10 and Exacerbated by Endogenous IL-10 Deficiency
Autoimmunity, 1999, 31, 75-83
3.166Citations (PDF)
251Endogenous interleukin‐12 only plays a key pathogenetic role in non‐obese diabetic mouse diabetes during the very early stages of the disease
Immunology, 1999, 97, 367-370
4.727Citations (PDF)
252Chronic Administration of UK-114, a Multifunctional Emerging Protein, Modulates the Th1/Th2 Cytokine Pattern and Experimental Autoimmune Diseases4.015Citations (PDF)
253Prevention by rolipram of concanavalin A-induced T-cell-dependent hepatitis in mice4.38Citations (PDF)
254Induction of experimental autoimmune thyroiditis by heat-denatured porcine thyroglobulin: a Tc1-mediated disease
European Journal of Immunology, 1999, 29, 1342-1352
3.28Citations (PDF)
255The involvement of IL-12 in murine experimentally induced autoimmune thyroid disease
European Journal of Immunology, 1999, 29, 1933-1942
3.240Citations (PDF)
256Amelioration of Experimental Allergic Neuritis by Sodium Fusidate (Fusidin): Suppression of IFN-γ and TNF-α and Enhancement of IL-10
Journal of Autoimmunity, 1999, 13, 187-195
6.619Citations (PDF)
257Deoxyspergualin neither counteracts lipopolysaccharide (LPS) or Staphylococcus aureus enterotoxin-B (SEB) induced lethality in mice nor does it modulate the release of tumor necrosis factor-α
Immunology Letters, 1998, 61, 63-66
2.41Citations (PDF)
258Human anticardiolipin monoclonal autoantibodies cause placental necrosis and fetal loss in BALB/c mice
Arthritis and Rheumatism, 1998, 41, 1026-1039
6.196Citations (PDF)
259MACROPHAGE-DERIVED CYTOKINES IN THE FOLLICULAR FLUIDS OF WOMEN WITH INFERTILITY DUE TO IMMUNOLOGICAL CAUSES. ELEVATED LEVELS OF INTERLEUKIN 6 AND LOW LEVELS OF GRANULOCYTE–MACROPHAGE COLONY-STIMULATING FACTOR
Cytokine, 1998, 10, 814-818
3.518Citations (PDF)
260Paradoxical Antidiabetogenic Effect of γ-Interferon in DP-BB Rats
Diabetes, 1998, 47, 32-38
4.233Citations (PDF)
261Immunomodulation of murine experimental SLE-like disease by interferon-γ
Lupus, 1998, 7, 445-454
1.717Citations (PDF)
262Antibiotic Susceptibility of Group A Streptococci in 2 Italian Cities: Milano and Catania
Microbial Drug Resistance, 1997, 3, 379-384
2.114Citations (PDF)
263Prevention of Spontaneous Autoimmune Diabetes in Diabetes-Prone BB Rats by Prophylactic Treatment with Antirat Interferon-γ Antibody
Endocrinology, 1997, 138, 281-288
2.549Citations (PDF)
264Effects of octreotide on glycaemic control, glucose disposal, hepatic glucose production and counterregulatory hormones secretion in type 1 and type 2 insulin treated diabetic patients5.919Citations (PDF)
265Prevention of endotoxin-induced lethality in neonatal mice by interleukin-13
European Journal of Immunology, 1997, 27, 1580-1583
3.271Citations (PDF)
266Prevention of Spontaneous Autoimmune Diabetes in Diabetes-Prone BB Rats by Prophylactic Treatment with Antirat Interferon-  Antibody
Endocrinology, 1997, 138, 281-288
2.514Citations (PDF)
267Immunosuppressive activity of 15-deoxyspergualin on normal and autoimmune peripheral blood mononuclear cells4.35Citations (PDF)
268CIRCULATING SERUM LEVELS OF IL-1ra IN PATIENTS WITH RELAPSING REMITTING MULTIPLE SCLEROSIS ARE NORMAL DURING REMISSION PHASES BUT SIGNIFICANTLY INCREASED EITHER DURING EXACERBATIONS OR IN RESPONSE TO IFN-β TREATMENT
Cytokine, 1996, 8, 395-400
3.582Citations (PDF)
269Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis2.3115Citations (PDF)
270Effect of octreotide on blood glucose and counterregulatory hormones in insulin-dependent diabetic patients: the role of dose and route of administration2.07Citations (PDF)
271In vitro type-1 and type-2 cytokine production in systemic lupus erythematosus: lack of relationship with clinical disease activity
Lupus, 1996, 5, 139-145
1.764Citations (PDF)
272Fusidic Acid and Insulin-Dependent Diabetes Mellitus
Autoimmunity, 1996, 24, 187-197
3.111Citations (PDF)
273The effects of a nonimmunogenic form of murine soluble interferon-gamma receptor on the development of autoimmune diabetes in the NOD mouse.
Endocrinology, 1996, 137, 5567-5575
2.564Citations (PDF)
274The effects of a nonimmunogenic form of murine soluble interferon-gamma receptor on the development of autoimmune diabetes in the NOD mouse
Endocrinology, 1996, 137, 5567-5575
2.523Citations (PDF)
275Biphasic effect of interferon-γ in murine collagen-induced arthritis
European Journal of Immunology, 1995, 25, 1184-1190
3.2191Citations (PDF)
276Placental Thrombosis and Fetal Loss After Passive Transfer of Mouse Lupus Monoclonal or Human Polyclonal Anti-Cardiolipin Antibodies in Pregnant Naive BALB/c Mice1.474Citations (PDF)
277Protection from experimental autoimmune diabetes in the non‐obese diabetic mouse with soluble interleukin‐1 receptor
European Journal of Immunology, 1994, 24, 1843-1847
3.2101Citations (PDF)
278Protection from Experimental Autoimmune Thyroiditis in CBA Mice with the Novel Immunosuppressant Deoxyspergualin1.410Citations (PDF)
279The Effects of Thymopentin on the Development of SLE-Like Syndrome in the MRL/lpr-lpr Mouse1.47Citations (PDF)
280The effects of a monoclonal antibody to interferon-γ on experimental autoimmune thyroiditis (EAT): prevention of disease and decrease of EAT-specific T cells3.282Citations (PDF)
281The Effect of Cefepime on Some Immune ParametersIn Vitro:Lack of Interference with Mitogen-Induced Lymphoproliferation, Immunoglobulin Synthesis, IFN-Gamma and IL-2 Secretion and IL-2 Receptor Expression
Journal of Chemotherapy, 1993, 5, 297-301
1.54Citations (PDF)
282Increased Rate of Survival in Streptococcus pneumoniae-Infected Rats Treated with the New Immunomodulator Pidotimod1.56Citations (PDF)
283Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cells1.871Citations (PDF)
284Enrichment of IgG anti-DNA-producing lymphoblastoid cell lines by antigen-coated immunomagnetic beads1.84Citations (PDF)
285Thyrotropin releasing hormone (TRH) and its analog, RGH-2202, accelerate maturation of cerebellar neurons in vitro
Developmental Brain Research, 1992, 69, 179-183
2.112Citations (PDF)
286The Effects of Deoxyspergualin on the Development of Diabetes in Diabetes-Prone BB Rats1.418Citations (PDF)
287In vivo treatment with a monoclonal antibody to interferon-gamma neither affects the survival nor the incidence of lupus-nephritis in the MRL/lpr-lpr mouse
Immunopharmacology, 1992, 24, 11-16
3.627Citations (PDF)
288Enhanced Percent Age of Leu M3+Dr+and Leu M3+Cd25+Cells in Newly Diagnosed Iddm Patients
Autoimmunity, 1991, 9, 255-259
3.12Citations (PDF)
289FK-506 prevents diabetes in diabetes-prone BB/Wor rats1.312Citations (PDF)
290Enhanced percentage of CD5+ B lymphocytes in newly diagnosed IDDM patients
Immunology Letters, 1990, 23, 211-215
2.419Citations (PDF)
291Correlation between islet cell antibodies and anti-cytomegalovirus IgM and IgG antibodies in healthy first-degree relatives of type 1 (insulin-dependent) diabetic patients1.827Citations (PDF)
292Receptor-mediated stimulation of inositol phospholipid hydrolysis in human brain4.314Citations (PDF)
293Detection of inositol trisphosphate and other organic phosphates by high-performance liquid chromatography using an enzyme-loaded post-column reactor
Journal of Chromatography A, 1986, 351, 303-311
3.749Citations (PDF)
294Comparative Effects of Estradiol Benzoate, the Antiestrogen Clomiphene Citrate, and the Progestin Medroxyprogesterone Acetate on Kainic Acid‐Induced Seizures in Male and Female Rats
Epilepsia, 1985, 26, 252-257
4.4105Citations (PDF)